GB1179131A - Process for the Preparation of Erythrocytes Suitable for Immunochemical Determinations and the Manufacture of Dosage Unit Forms therefrom. - Google Patents
Process for the Preparation of Erythrocytes Suitable for Immunochemical Determinations and the Manufacture of Dosage Unit Forms therefrom.Info
- Publication number
- GB1179131A GB1179131A GB03515/67A GB1351567A GB1179131A GB 1179131 A GB1179131 A GB 1179131A GB 03515/67 A GB03515/67 A GB 03515/67A GB 1351567 A GB1351567 A GB 1351567A GB 1179131 A GB1179131 A GB 1179131A
- Authority
- GB
- United Kingdom
- Prior art keywords
- erythrocytes
- hcg
- preparation
- march
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000003743 erythrocyte Anatomy 0.000 title abstract 5
- 230000000984 immunochemical effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 5
- 206010070834 Sensitisation Diseases 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 229920002472 Starch Polymers 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 230000008313 sensitization Effects 0.000 abstract 2
- 235000019698 starch Nutrition 0.000 abstract 2
- 239000008107 starch Substances 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 241001494479 Pecora Species 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000001235 sensitizing effect Effects 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 235000018553 tannin Nutrition 0.000 abstract 1
- 229920001864 tannin Polymers 0.000 abstract 1
- 239000001648 tannin Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N33/555—Red blood cell
- G01N33/556—Fixed or stabilised red blood cell
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL6603909A NL6603909A (enrdf_load_html_response) | 1966-03-24 | 1966-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1179131A true GB1179131A (en) | 1970-01-28 |
Family
ID=19796083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB03515/67A Expired GB1179131A (en) | 1966-03-24 | 1967-03-22 | Process for the Preparation of Erythrocytes Suitable for Immunochemical Determinations and the Manufacture of Dosage Unit Forms therefrom. |
Country Status (12)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0356258A3 (en) * | 1988-08-26 | 1990-06-06 | Cryopharm Corporation | Processes for the lyophilization of red blood cells, together with media for lyophilization |
| US5340592A (en) * | 1988-05-18 | 1994-08-23 | Cobe Laboratories, Inc. | Lyophilization of erythrocytes |
| US5425951A (en) * | 1988-05-18 | 1995-06-20 | Cryopharm Corporation | Method of reconstituting lyophilized cells |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3655838A (en) * | 1969-03-20 | 1972-04-11 | Organon | Method of pelletizing analytical or immunological reagents |
| DE2310964A1 (de) * | 1973-03-02 | 1974-09-05 | Schering Ag | Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation |
| US4136161A (en) * | 1976-03-16 | 1979-01-23 | Ortho Diagnostics, Inc. | Stabilized erythrocytes and methods therefor |
| JPS55162059A (en) * | 1979-06-05 | 1980-12-17 | Mochida Pharmaceut Co Ltd | Measuring method for antigen, antibody or their complex and measurement reagent kit |
| US4282002A (en) * | 1979-09-06 | 1981-08-04 | Akzona Incorporated | Sensitized sheep stroma immunoassay for rheumatoid factor |
| FR2476320B1 (fr) * | 1980-02-15 | 1985-10-25 | Guffroy Rene | Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif |
| US4609630A (en) * | 1983-03-23 | 1986-09-02 | Yanovsky Jorge F | Method for improving the specificity of immunoassays |
| WO2005072523A2 (en) * | 2004-02-02 | 2005-08-11 | I.M.T. Interface Multigrad Technology Ltd. | Biological material and methods and solutions for preservation thereof |
| CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
| JP7471316B2 (ja) | 2019-03-14 | 2024-04-19 | テルモ ビーシーティー バイオテクノロジーズ，エルエルシー | マルチパート凍結乾燥容器 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3096250A (en) * | 1959-11-30 | 1963-07-02 | Indiana University Foundation | Novel particulate antigens and process |
| US3236732A (en) * | 1962-01-22 | 1966-02-22 | Edward R Arquilla | Pregnancy test method and immunological indicator therefor |
-
0
- NL NL126572D patent/NL126572C/xx active
-
1966
- 1966-03-24 NL NL6603909A patent/NL6603909A/xx unknown
-
1967
- 1967-03-12 IL IL27578A patent/IL27578A/xx unknown
- 1967-03-17 US US623825A patent/US3548051A/en not_active Expired - Lifetime
- 1967-03-18 ES ES338201A patent/ES338201A1/es not_active Expired
- 1967-03-20 DE DE19671617672 patent/DE1617672A1/de active Pending
- 1967-03-21 CH CH412467A patent/CH508390A/de not_active IP Right Cessation
- 1967-03-22 GB GB03515/67A patent/GB1179131A/en not_active Expired
- 1967-03-22 DK DK155467AA patent/DK126452B/da unknown
- 1967-03-22 GR GR670136578A patent/GR36578B/el unknown
- 1967-03-23 AT AT284467A patent/AT270864B/de active
- 1967-03-23 SE SE04108/67A patent/SE335592B/xx unknown
- 1967-03-24 BE BE696050D patent/BE696050A/xx unknown
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340592A (en) * | 1988-05-18 | 1994-08-23 | Cobe Laboratories, Inc. | Lyophilization of erythrocytes |
| US5425951A (en) * | 1988-05-18 | 1995-06-20 | Cryopharm Corporation | Method of reconstituting lyophilized cells |
| EP0356258A3 (en) * | 1988-08-26 | 1990-06-06 | Cryopharm Corporation | Processes for the lyophilization of red blood cells, together with media for lyophilization |
| US5648206A (en) * | 1988-08-26 | 1997-07-15 | Cobe Laboratories, Inc. | Lyophilization of cells |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1617672A1 (de) | 1971-04-01 |
| SE335592B (enrdf_load_html_response) | 1971-06-01 |
| IL27578A (en) | 1971-04-28 |
| NL6603909A (enrdf_load_html_response) | 1967-09-25 |
| CH508390A (de) | 1971-06-15 |
| GR36578B (el) | 1969-02-21 |
| DK126452B (da) | 1973-07-16 |
| ES338201A1 (es) | 1968-04-01 |
| NL126572C (enrdf_load_html_response) | |
| AT270864B (de) | 1969-05-12 |
| BE696050A (enrdf_load_html_response) | 1967-09-25 |
| US3548051A (en) | 1970-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1179131A (en) | Process for the Preparation of Erythrocytes Suitable for Immunochemical Determinations and the Manufacture of Dosage Unit Forms therefrom. | |
| GB1159629A (en) | Analytical Reference Standard | |
| ES249137A1 (es) | Procedimiento para la preparacion de reactivos para su uso en el control de la coagulabilidad de la sangre | |
| ES352693A1 (es) | Un metodo de ensayar en la sangre la presencia de hemoglo- bina s. | |
| GB1359232A (en) | Liquid blood serum control standard | |
| GB1036591A (en) | Immunological reagent for gonadotropins | |
| GB1343528A (en) | Substitute product for nonfat dry milk and method for forming | |
| Johnson et al. | Ascorbic acid therapy of pteroylglutamic acid-deficient rats | |
| GB1396219A (en) | Method and reagent for testing blood | |
| GB1144215A (en) | Process for treating erythrocytes and the manufacture of tablet therefrom | |
| Bock et al. | Tumour-promoting agents in unburned cigarette tobacco | |
| Lauf et al. | Pig reticulocytes. V. Development of Rb+ influx during in vitro maturation | |
| Nutbourne | The effect of dilution on the titratable acid in urine and acidified phosphate buffer solutions, and the correction for this effect in the determination of the rate of elimination of hydrogen ions from the body by the renal tubules | |
| GB979759A (en) | Reagents for the determination of gonadotropins and method for the preparation and use of said reagents | |
| GB1222810A (en) | Prothrombin complex | |
| Taylor et al. | Uniformities in the content of B vitamins in malignant neoplasms | |
| Guschlbauer et al. | Appearance of proteins in regenerating wound tissue | |
| GB1324937A (en) | Process for the preparation of a calcium salt solution with calcium effect pharmaceutical preparation having calcium effect as well as a method for treating calcium deficiency | |
| Chopra | The Significance of Triiodothyronine | |
| GB1509284A (en) | Method for use in the determination of the concentration of luteinizing hormone(lh) | |
| GB1013192A (en) | Diagnostic reagent composition for use in determining blood coagulation factors | |
| West et al. | Production of superoxide by neutrophils | |
| GB1310865A (en) | Method of treating cotton for fire retardation | |
| GB1356503A (en) | Diagnostic method and means therefor | |
| GB918754A (en) | Improvements in or relating to corticotrophin preparations |